Zydus granted approval to market Benazepril in US - Pharmaceutical Business review

27 May 2008

Zydus granted approval to market Benazepril in US

Zydus Cadila has received an approval from the FDA to market Benazepril tablets 5, 10, 20 and 40mg in the US.

The drug falls in the cardiovascular segment and the combined sales of all the strengths as per NDC was estimated at $301 million in 2007.

This marks the 38th abbreviated new drug application approval (ANDA) for the group. So far, the group has filed 78 ANDAs and 59 drug master files.

Drug Discovery